TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20926027

Group type: EXPERIMENTAL
Intervention: High-dose vitamin C (0.06 g/kg bolus followed by 0.02 g/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no intra-operative vitamin C)
Number of subjects: 32
Study: 17432646

Group type: EXPERIMENTAL
Intervention: Warming needle moxibustion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acupuncture plus TDP radiation
Number of subjects: 80
Study: 15818529

Group type: EXPERIMENTAL
Intervention: Acute day hospital care
Number of subjects: 144

Group type: COMPARATOR
Intervention: Inpatient care
Number of subjects: 144
Study: 12196880

Group type: EXPERIMENTAL
Intervention: Rectal misoprostol (400 microg)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Parenteral oxytocin (5 units i.v. or 10 units i.m.)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (excessive third stage bleeding, duration of third stage of labour, need for manual removal of the placenta or the need for additional oxytocics)
Number of subjects: 240
Study: 10223249

Group type: EXPERIMENTAL
Intervention: CA125 elevation (> or =30 U/mL)
Number of subjects: 1542

Group type: COMPARATOR
Intervention: CA125 <30 U/mL
Number of subjects: 1542
Study: 8697999

Group type: EXPERIMENTAL
Intervention: Partial esophagectomy, partial gastrectomy and end‐to‐side esophagogastric anastomosis with fundoplication
Number of subjects: 193

Group type: COMPARATOR
Intervention: End‐to‐end esophagogastrostomy
Number of subjects: 193
Study: 2129633

Group type: EXPERIMENTAL
Intervention: 10 mg omeprazole o.m.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole o.m.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole o.m.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine b.d.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All doses of omeprazole
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Drug-induced hypochlorhydria
Number of subjects: 48
Study: 34336

Group type: EXPERIMENTAL
Intervention: Beta-adrenoceptor blockade during anaesthesia
Number of subjects: 26
Study: 31973744

Group type: EXPERIMENTAL
Intervention: Fixed cash payment incentive
Number of subjects: 1740

Group type: EXPERIMENTAL
Intervention: Lottery payment incentive
Number of subjects: 1740

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1740
Study: 30593693

Group type: EXPERIMENTAL
Intervention: Heat stress (32 ± 2°C)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal temperature (20 ± 2°C)
Number of subjects: 48
Study: 28231372

Group type: EXPERIMENTAL
Intervention: Submucosal bipolar radiofrequency turbinate volume reduction (RFTVR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency-assisted turbinectomy (RFaT)
Number of subjects: 30
Study: 25981966

Group type: EXPERIMENTAL
Intervention: Higher produce environment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Better neighborhood access to produce
Number of subjects: 0
Study: 23692526

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirabegron 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mirabegron 25 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tolterodine ER 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21247663

Group type: EXPERIMENTAL
Intervention: Aquaphor Healing Ointment (AHO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Polysporin first‐aid ointment (Poly/Bac)
Number of subjects: 20
Study: 19570440

Group type: EXPERIMENTAL
Intervention: Motherwort injection (40 mg uterine injection during CS and 20 mg intramuscular injection per 12 hours 3 times after CS)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Motherwort + Oxytocin (40 mg motherwort and 10 U oxytocin uterine injection during CS; 20 mg motherwort intramuscular injection per 12 hours 3 times after CS)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Oxytocin (10 U uterine injection and 10 U+5% glucose 500 ml intravenously during operation; 10 U intramuscular injection per 12 hours 3 times after CS)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Motherwort injection
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Motherwort + Oxytocin
Number of subjects: 440

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 440
Study: 17522285

Group type: EXPERIMENTAL
Intervention: Peer-based academic detailing intervention involving a physician, nurse, and office manager delivering educational presentations and developing action plans.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer-based academic detailing intervention
Number of subjects: 0
Study: 15928300

Group type: EXPERIMENTAL
Intervention: 8 Gy in one treatment fraction
Number of subjects: 898

Group type: COMPARATOR
Intervention: 30 Gy in 10 treatment fractions
Number of subjects: 898
Study: 12711105

Group type: EXPERIMENTAL
Intervention: Chloroquine 25 mg base/kg given unsupervised by mothers at home
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloroquine 25 mg base/kg given supervised at a health centre
Number of subjects: 0
Study: 10472159

Group type: EXPERIMENTAL
Intervention: lifestyle physical activity
Number of subjects: 38

Group type: COMPARATOR
Intervention: traditional aerobic activity
Number of subjects: 38
Study: 8911949

Group type: EXPERIMENTAL
Intervention: Pilocarpine TDS (30 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo TDS
Number of subjects: 24
Study: 1921686

Group type: EXPERIMENTAL
Intervention: Diltiazem (180 mg) and Propranolol (80 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Active drug (Diltiazem and Propranolol) after placebo
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 7029290

Group type: EXPERIMENTAL
Intervention: Adriamycin (ADR) 30 mg/m2/day for 3 successive days every 4 weeks for 6 courses
Number of subjects: 62

Group type: COMPARATOR
Intervention: Alternating Adriamycin (ADR) and high-dose methotrexate followed by citrovorum factor rescue (HDMTX-CFR)
Number of subjects: 62
Study: 30590813

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Secukinumab 75 mg
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Secukinumab up-titrators (n=25)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 274
Study: 27707001

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of fentanyl citrate and propofol lipid emulsion (PLE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sequential administration of fentanyl citrate and propofol lipid emulsion (PLE)
Number of subjects: 0
Study: 26376528

Group type: EXPERIMENTAL
Intervention: Pyramidalis muscle left attached to the rectus muscles (Group I)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Preservation of the connection between the pyramidalis muscle and the rectus sheath (Group II)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Group I (Control)
Number of subjects: 108
Study: 24912398

Group type: EXPERIMENTAL
Intervention: Supportive counselling
Number of subjects: 280
Study: 23072077

Group type: EXPERIMENTAL
Intervention: Lung meridian acupoint group (group A)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Large intestine meridian acupoint group (group B)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Lung and large intestine meridian acupoint group (group C)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (Ventolin aerosol)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Comparison between group B and group C
Number of subjects: 52
Study: 18564281

Group type: EXPERIMENTAL
Intervention: 0.05% capsaicin gel applied once daily for 5 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vehicle (control) applied once daily for 5 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aged group (older than 65 years)
Number of subjects: 100
Study: 17482520

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 28
Study: 15022445

Group type: EXPERIMENTAL
Intervention: Endoscopic recanalization under transrectal ultrasonic control
Number of subjects: 242

Group type: COMPARATOR
Intervention: Open reconstructive-plastic operations
Number of subjects: 242
Study: 12220694

Group type: EXPERIMENTAL
Intervention: Vitamin B12 (1500 microg/day)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg/day)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Combined therapy with folic acid and vitamin B12
Number of subjects: 191
Study: 9766695

Group type: EXPERIMENTAL
Intervention: Trazodone hydrochloride
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7709405

Group type: EXPERIMENTAL
Intervention: CGS 19755 (1.5 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CGS 19755 (2 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CGS 19755 (1.75 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CGS 19755 (1.0 mg/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CGS 19755 (all doses)
Number of subjects: 32
Study: 2676792

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.75% bupivacaine/2% mepivacaine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine with 75 IU hyaluronidase
Number of subjects: 100
Study: 620896

Group type: EXPERIMENTAL
Intervention: Glucagon, 2 mg given intravenously before aspirin instillation
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Glucagon, 2 mg given intravenously
Number of subjects: 27

Group type: COMPARATOR
Intervention: Aspirin, 600 mg suspended in 100 ml of isotonic saline
Number of subjects: 27
Study: 31703934

Group type: EXPERIMENTAL
Intervention: IPV-Al
Number of subjects: 1002

Group type: COMPARATOR
Intervention: IPV
Number of subjects: 1002
Study: 31200945

Group type: EXPERIMENTAL
Intervention: Oral protein supplementation (30 grams of whey, three days/week during dialysis)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Protein plus exercise (30-45 minutes of cycling during dialysis treatment, three days/week)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Protein and protein plus exercise groups
Number of subjects: 138
Study: 28877027

Group type: EXPERIMENTAL
Intervention: Tiotropium (18 μg once daily)
Number of subjects: 841

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 841
Study: 25042896

Group type: EXPERIMENTAL
Intervention: Diabetes management (using HbA1C as the indicator)
Number of subjects: 5900

Group type: EXPERIMENTAL
Intervention: Occasional opium use
Number of subjects: 5900

Group type: EXPERIMENTAL
Intervention: Depression and anxiety in diagnosed diabetes
Number of subjects: 5900

Group type: EXPERIMENTAL
Intervention: Diabetes management effectiveness
Number of subjects: 5900

Group type: EXPERIMENTAL
Intervention: Overweight and obesity
Number of subjects: 5900

Group type: EXPERIMENTAL
Intervention: Low physical activity
Number of subjects: 5900
Study: 22901550

Group type: EXPERIMENTAL
Intervention: Milk intakes
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Calcium intakes
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: 25(OH)D
Number of subjects: 227
Study: 21104227

Group type: EXPERIMENTAL
Intervention: Alendronate (35 mg weekly)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Elcatonin (intramuscular 20 units a week)
Number of subjects: 194
Study: 19059753

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Therapy with Attention Training (CBGT + ATT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Relaxation Training (RT)
Number of subjects: 81
Study: 17090233

Group type: EXPERIMENTAL
Intervention: Impedance respirometry
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (oesophageal intubation)
Number of subjects: 80
Study: 15509131

Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg and HCTZ 12.5 mg once daily (n=46)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Amlodipine 10 mg alone once daily (n=46)
Number of subjects: 92
Study: 11345748

Group type: EXPERIMENTAL
Intervention: Sevoflurane (group S)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Sevoflurane with premedication (group MS)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Propofol with premedication (group MP)
Number of subjects: 104

Group type: COMPARATOR
Intervention: All groups (S, P, MS, MP)
Number of subjects: 104
Study: 9128126

Group type: EXPERIMENTAL
Intervention: Self-hypnosis relaxation techniques
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 32
Study: 7953396

Group type: EXPERIMENTAL
Intervention: Repeat cytology
Number of subjects: 60

Group type: COMPARATOR
Intervention: Core biopsy
Number of subjects: 60
Study: 3316516

Group type: EXPERIMENTAL
Intervention: Polychemotherapy as initial therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single new drug
Number of subjects: 0
Study: 31272939

Group type: EXPERIMENTAL
Intervention: Temsirolimus
Number of subjects: 69

Group type: COMPARATOR
Intervention: Pazopanib
Number of subjects: 69
Study: 30227659

Group type: EXPERIMENTAL
Intervention: Tocovid 200 mg twice a day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 27613934

Group type: EXPERIMENTAL
Intervention: Active progesterone (PRO; 200mg twice a day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 46
Study: 25630357

Group type: EXPERIMENTAL
Intervention: Couplelinks online intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 80
Study: 22986643

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) treatment for 6 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Euthyroid subjects (control group)
Number of subjects: 16
Study: 20067480

Group type: EXPERIMENTAL
Intervention: Rice hydrolysate formula
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Soy-based formula
Number of subjects: 72

Group type: COMPARATOR
Intervention: Extensively hydrolysed cow's milk formula
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Rice hydrolysate formula (in children not co-sensitized to soy)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Soy-based formula (in children not co-sensitized to soy)
Number of subjects: 72
Study: 18237596

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 155

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 155
Study: 16278080

Group type: EXPERIMENTAL
Intervention: SRL 172 (heat-killed Mycobacterium vaccae)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 12916291

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study: 12626207

Group type: EXPERIMENTAL
Intervention: Transcutaneous suture
Number of subjects: 334

Group type: COMPARATOR
Intervention: Intracutaneous suture
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Non-invasive surgical zipper
Number of subjects: 334
Study: 9536981

Group type: EXPERIMENTAL
Intervention: Sequential compression devices (Group 1)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Subcutaneous heparin (Group 2)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 136
Study: 8021331

Group type: EXPERIMENTAL
Intervention: Diltiazem CD 300 mg
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 2524573

Group type: EXPERIMENTAL
Intervention: Test dentifrice containing zinc citrate and Triclosan
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 34
Study: 4900147

Group type: EXPERIMENTAL
Intervention: Topical ampicillin powder
Number of subjects: 130

Group type: COMPARATOR
Intervention: Topical placebo powder (lactose)
Number of subjects: 130
Study: 30826725

Group type: EXPERIMENTAL
Intervention: Contingent lullaby music intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 66
Study: 27999056

Group type: EXPERIMENTAL
Intervention: Dolutegravir (DOLU group, n = 37)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Ritonavir-boosted PI (PI group, n = 36)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Dolutegravir (DOLU group)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Ritonavir-boosted PI (PI group)
Number of subjects: 73
Study: 26002297

Group type: EXPERIMENTAL
Intervention: Unicompartmental knee arthroplasty (UKA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 0
Study: 22751031

Group type: EXPERIMENTAL
Intervention: TSCORE (time-stamped pain scores)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Paper numerical rating scale
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: TSCORE
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: TLOG (monitoring TENS use)
Number of subjects: 42
Study: 20884221

Group type: EXPERIMENTAL
Intervention: On-pump without CA
Number of subjects: 81

Group type: COMPARATOR
Intervention: On-pump with CA
Number of subjects: 81
Study: 20006256

Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen (100 mcg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study: 17171539

Group type: EXPERIMENTAL
Intervention: Family‐based cognitive behavioural treatment for anxiety
Number of subjects: 47

Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 47
Study: 15102141

Group type: EXPERIMENTAL
Intervention: Anger
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sadness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral state
Number of subjects: 0
Study: 11340513

Group type: EXPERIMENTAL
Intervention: Topical 10% povidone-iodine solution applied on the periocular skin and 5% povidone-iodine solution instilled on the forniceal conjunctiva the day before and one hour before surgery.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Usual perioperative disinfectant (control group).
Number of subjects: 82
Study: 9114989

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loracarbef
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefadroxyl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dicloxacillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxacillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erythromycin/Sulfisoxazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefpodoxime
Number of subjects: 0
Study: 7942325

Group type: EXPERIMENTAL
Intervention: aceclofenac
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: diclofenac
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: aceclofenac and diclofenac
Number of subjects: 30
Study: 3295676

Group type: EXPERIMENTAL
Intervention: Meclofenamate therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 18
Study: 31046405

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg/d for 3 days, then 250 mg/2 days for 3 months)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 301
Study: 27868230

Group type: EXPERIMENTAL
Intervention: Active continuous TENS (n=12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo TENS (n=12)
Number of subjects: 24
Study: 26112044

Group type: EXPERIMENTAL
Intervention: Healthy Eating (HE)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Physical Activity (PA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: HE+PA
Number of subjects: 150
Study: 23933267

Group type: EXPERIMENTAL
Intervention: Playground markings (EG)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 420
Study: 21972329

Group type: EXPERIMENTAL
Intervention: Collaborative care for treating depression in patients with cardiac disease
Number of subjects: 0
Study: 19632964

Group type: EXPERIMENTAL
Intervention: Timed Up & Go (TUG) test for stroke subjects
Number of subjects: 44

Group type: COMPARATOR
Intervention: Timed Up & Go (TUG) test for control subjects
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: TUG trials for stroke subjects
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Correlation of fear of falling with TUG performance in stroke subjects
Number of subjects: 44

Group type: COMPARATOR
Intervention: Correlation of fear of falling with TUG performance in control subjects
Number of subjects: 44
Study: 16722793

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Dorzolamide 2%
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 44
Study: 15246580

Group type: EXPERIMENTAL
Intervention: CPR + AED units
Number of subjects: 0

Group type: COMPARATOR
Intervention: CPR only units
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CPR + AED method
Number of subjects: 0

Group type: COMPARATOR
Intervention: CPR only approach
Number of subjects: 0
Study: 11740216

Group type: EXPERIMENTAL
Intervention: Partial ligation of silicone tube in Ahmed glaucoma valve implantation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Nonligation of silicone tube in Ahmed glaucoma valve implantation
Number of subjects: 32
Study: 9247458

Group type: EXPERIMENTAL
Intervention: Attention (anticipatory knowledge)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Attention plus somatic TENS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Distraction plus somatic TENS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Somatic TENS
Number of subjects: 16